NDLI: Diacylglycerol Acyltransferase 2 Inhibitors

Please wait, while we are loading the content...

Diacylglycerol Acyltransferase 2 Inhibitors

Content Provider	The Lens
Related Links	https://www.lens.org/lens/patent/010-941-197-409-595/frontpage
Language	English
Publisher Date	2019-06-26
Access Restriction	Open
Alternative Title	Diacylglycerol-acyltransferase-2-hemmer Inhibiteurs De Diacylglycérol Acyltransférase 2
Content Type	Text
Resource Type	Patent
Date Applied	2017-08-09
Agent	Pfizer
Applicant	Pfizer
Application No.	17761332
CPC Classification	Preparations For Medical; Dental Or Toiletry Purposes HETEROCYCLIC COMPOUNDS GENERAL METHODS OF ORGANIC CHEMISTRY;APPARATUS THEREFOR Specific Therapeutic Activity Of Chemical Compounds Or Medicinal Preparations
Extended Family	097-341-565-321-528 056-258-284-764-985 112-878-320-209-433 107-922-361-515-642 055-276-645-953-988 154-924-132-289-219 111-850-354-041-033 005-894-195-726-941 139-368-439-003-424 052-228-311-384-855 129-404-416-141-560 046-623-404-472-603 197-270-067-602-263 047-659-978-611-351 155-461-378-713-479 080-191-697-240-510 120-959-213-009-924 042-592-988-722-551 174-101-433-330-885 104-792-131-952-263 178-488-854-473-555 171-631-346-653-642 153-627-525-437-326 078-265-082-954-012 184-543-336-157-567 117-476-959-077-435 003-116-593-889-582 139-691-917-161-700 087-288-236-608-728 010-941-197-409-595 055-915-258-015-690 082-961-533-489-791 075-059-064-667-275 078-222-969-519-388 166-962-643-339-794 004-073-540-258-209 118-392-581-225-78X 182-964-315-725-046 127-792-674-345-640 023-195-782-192-892 195-751-833-354-356 047-228-605-226-261 006-311-076-864-97X 085-456-851-992-212 078-472-028-857-862 140-571-183-803-485 110-067-451-893-368 045-468-637-100-591 074-881-864-262-583 188-263-909-805-373 096-260-753-999-722 161-887-056-744-534 183-027-329-479-157 135-538-997-574-233 075-387-302-981-802 112-302-839-827-703 165-824-452-438-704 047-172-579-044-471 089-731-602-181-450 139-942-743-816-984 118-852-074-466-874 053-212-419-544-603
Patent ID	3500564
Inventor/Author	Boehm Markus Cabral Shawn Dowling Matthew S Futatsugi Kentaro Huard Kim Lee Esther Cheng Yin Li Qifang Londregan Allyn T Polivkova Jana Price David A
IPC	C07D401/14 A61K31/506 A61P3/00
Status	Active
Owner	Pfizer Inc. (n.d.ges.d.staates Delaware), New , Us Pfizer Inc., Us Pfizer Inc.; Us Pfizer Inc., New York, Ny, Us
Simple Family	097-341-565-321-528 056-258-284-764-985 112-878-320-209-433 107-922-361-515-642 055-276-645-953-988 154-924-132-289-219 111-850-354-041-033 005-894-195-726-941 139-368-439-003-424 052-228-311-384-855 129-404-416-141-560 046-623-404-472-603 197-270-067-602-263 047-659-978-611-351 155-461-378-713-479 080-191-697-240-510 120-959-213-009-924 042-592-988-722-551 174-101-433-330-885 104-792-131-952-263 178-488-854-473-555 171-631-346-653-642 153-627-525-437-326 078-265-082-954-012 184-543-336-157-567 117-476-959-077-435 003-116-593-889-582 139-691-917-161-700 087-288-236-608-728 010-941-197-409-595 055-915-258-015-690 082-961-533-489-791 075-059-064-667-275 078-222-969-519-388 166-962-643-339-794 004-073-540-258-209 118-392-581-225-78X 182-964-315-725-046 127-792-674-345-640 023-195-782-192-892 195-751-833-354-356 047-228-605-226-261 006-311-076-864-97X 085-456-851-992-212 078-472-028-857-862 140-571-183-803-485 110-067-451-893-368 045-468-637-100-591 074-881-864-262-583 188-263-909-805-373 096-260-753-999-722 161-887-056-744-534 183-027-329-479-157 135-538-997-574-233 075-387-302-981-802 112-302-839-827-703 165-824-452-438-704 047-172-579-044-471 089-731-602-181-450 139-942-743-816-984 118-852-074-466-874 053-212-419-544-603
CPC (with Group)	A61K31/506 A61K45/06 C07D401/14 C07D405/14 C07D409/14 C07B2200/13 A61P1/04 A61P1/16 A61P13/12 A61P15/10 A61P19/02 A61P19/10 A61P25/00 A61P25/18 A61P25/28 A61P27/02 A61P27/06 A61P27/12 A61P29/00 A61P3/00 A61P3/04 A61P3/06 A61P3/10 A61P43/00 A61P7/02 A61P7/06 A61P9/00 A61P9/04 A61P9/10 A61P9/12 A61P19/04
Issuing Authority	United States Patent and Trademark Office (USPTO)
Kind	Patent Application Publication

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in